Stanford V regimen: Difference between revisions

	WikiDoc Resources for Stanford V regimen
Articles
Most recent articles on Stanford V regimen Most cited articles on Stanford V regimen Review articles on Stanford V regimen Articles on Stanford V regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Stanford V regimen Images of Stanford V regimen Photos of Stanford V regimen Podcasts & MP3s on Stanford V regimen Videos on Stanford V regimen
Evidence Based Medicine
Cochrane Collaboration on Stanford V regimen Bandolier on Stanford V regimen TRIP on Stanford V regimen
Clinical Trials
Ongoing Trials on Stanford V regimen at Clinical Trials.gov Trial results on Stanford V regimen Clinical Trials on Stanford V regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Stanford V regimen NICE Guidance on Stanford V regimen NHS PRODIGY Guidance FDA on Stanford V regimen CDC on Stanford V regimen
Books
Books on Stanford V regimen
News
Stanford V regimen in the news Be alerted to news on Stanford V regimen News trends on Stanford V regimen
Commentary
Blogs on Stanford V regimen
Definitions
Definitions of Stanford V regimen
Patient Resources / Community
Patient resources on Stanford V regimen Discussion groups on Stanford V regimen Patient Handouts on Stanford V regimen Directions to Hospitals Treating Stanford V regimen Risk calculators and risk factors for Stanford V regimen
Healthcare Provider Resources
Symptoms of Stanford V regimen Causes & Risk Factors for Stanford V regimen Diagnostic studies for Stanford V regimen Treatment of Stanford V regimen
Continuing Medical Education (CME)
CME Programs on Stanford V regimen
International
Stanford V regimen en Espanol Stanford V regimen en Francais
Business
Stanford V regimen in the Marketplace Patents on Stanford V regimen
Experimental / Informatics
List of terms related to Stanford V regimen

VisualWikitext

Latest revision as of 16:24, 31 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Stanford V; Stanford V Regimen; Stanford V regimen

Overview

Stanford V regimen refers to a chemotherapy regimen consisting of mechlorethamine, doxorubicin hydrochloride, vinblastine, vincristine, bleomycin, etoposide and prednisone, administered on a compressed schedule and used in the treatment of Hodgkin lymphoma; it may be followed by consolidative radiation therapy.^[1]^[2]

Regimen

Mechlorethamine

Doxorubicin

Vinblastine

Vincristine

Bleomycin

Etoposide

Prednisone

Indications

Hodgkin's lymphoma^[1]

References

↑ ^1.0 ^1.1 Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A; et al. (2010). "Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience". Ann Oncol. 21 (3): 574–81. doi:10.1093/annonc/mdp337. PMID 19759185.
↑ "NCI Thesaurus".

[pmid19759185-1] 1.0 ^1.1 Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A; et al. (2010). "Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience". Ann Oncol. 21 (3): 574–81. doi:10.1093/annonc/mdp337. PMID 19759185.

[2] "NCI Thesaurus".

[1]

[2]

@@ Line 4: / Line 4: @@
 {{SK}}Stanford V; Stanford V Regimen; Stanford V regimen
 ==Overview==
@@ Line 10: / Line 9: @@
 ==Regimen==
-{{chemo|x|Mechlorethamine}}
+{{button|Mechlorethamine}}
-{{chemo|x|Doxorubicin hydrochloride}}
-{{chemo|x|Vinblastine}}
+{{button|Doxorubicin}}
-{{chemo|x|Vincristine}}
+{{button|Vinblastine}}
+{{button|Vincristine}}
-{{chemo|x|Bleomycin}}
+{{button|Bleomycin}}
-{{chemo|x|Etoposide}}
+{{button|Etoposide}}
-{{chemo|x|Prednisone}}
+{{button|Prednisone}}
 ==Indications==
+*[[Hodgkin's lymphoma]]<ref name="pmid19759185">{{cite journal| author=Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A et al.| title=Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. | journal=Ann Oncol | year= 2010 | volume= 21 | issue= 3 | pages= 574-81 | pmid=19759185 | doi=10.1093/annonc/mdp337 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19759185 }} </ref>
-*[[Hodgkin lymphoma]]<ref name="pmid19759185">{{cite journal| author=Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A et al.| title=Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. | journal=Ann Oncol | year= 2010 | volume= 21 | issue= 3 | pages= 574-81 | pmid=19759185 | doi=10.1093/annonc/mdp337 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19759185 }} </ref>
 ==References==
 {{Reflist|2}}
 [[Category:Chemotherapy regimens]]